Drugs Information: Nateglinide
Basic Information
|
||
| ID | DDInter1269 | |
| Drug Type | small molecule | |
| Molecular Formula | C19H27No3 | |
| Molecular Weight | 317.429 | |
| Description | Nateglinide is a meglitinide used to treat non insulin dependent diabetes mellitus. | |
| ATC Classification | A10BX03 | |
| IUPAC Name | (2R)-3-Phenyl-2-{[(1R,4R)-4-(Propan-2-Yl)Cyclohexyl]Formamido}Propanoic Acid | |
| InChI | Inchi=1S/C19H27No3/C1-13(2)15-8-10-16(11-9-15)18(21)20-17(19(22)23)12-14-6-4-3-5-7-14/H3-7,13,15-17H,8-12H2,1-2H3,(H,20,21)(H,22,23)/T15-,16-,17-/M1/S1 | |
| InChI Key | OELFLUMRDSZNSF-BRWVUGGUSA-N | |
| Canonical SMILES | CC(C)[C@H]1CC[C@@H](CC1)C(=O)N[C@H](CC1=CC=CC=C1)C(O)=O | |
| Useful Links | DrugBank ChEMBL PubChem | |
Interactions with Nateglinide
| Severity level | ID | Name | Mechanism | Detail |
|---|